Bioorganic and Medicinal Chemistry p. 2115 - 2137 (2004)
Update date:2022-08-05
Topics:
Takami, Atsuya
Iwakubo, Masayuki
Okada, Yuji
Kawata, Takehisa
Odai, Hideharu
Takahashi, Nobuaki
Shindo, Kazutoshi
Kimura, Kaname
Tagami, Yoshimichi
Miyake, Mika
Fukushima, Kayoko
Inagaki, Masaki
Amano, Mutsuki
Kaibuchi, Kozo
Iijima, Hiroshi
Several structurally unrelated scaffolds of the Rho kinase inhibitor were designed using pharmacophore information obtained from the results of a high-throughput screening and structural information from a homology model of Rho kinase. A docking simulation using the ligand-binding pocket of the Rho kinase model helped to comprehensively understand and to predict the structure-activity relationship of the inhibitors. This understanding was useful for developing new Rho kinase inhibitors of higher potency and selectivity. We identified several potent platforms for developing the Rho kinase inhibitors, namely, pyridine, 1H-indazole, isoquinoline, and phthalimide.
View MoreJiangxi Hito Chemical Co., Ltd.
Contact:+86-792-3170318
Address:No. 6, Tianhong Ave., Xinghuo Industry Park, Yongxiu, Jiujiang, Jiangxi, China
Zhonghao (dalian) Research and Design Institute of Chemical Industry Co., Ltd
Contact:+86 411 84674606
Address:201, Huangpu Road , Shahekou District, Dalian ,116023-China
Jiaxing Carry Bio-Chem Technology Co.,Ltd
website:http://www.carrybiotech.com
Contact:0573-82788958
Address:Add.Fl 3th, Pharm Vally,Kaichuang Rd, Xiuzhou District, Jiaxing, Zhejiang,314031,China
Huangshi Meifeng Chemical Co.,ltd.
Contact:+86-714-6516706
Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
Hubei Lingsheng Pharmaceuticals Co., Ltd.
Contact:+86-0710-3538058
Address:Xiangyang City Xiangcheng Economic Development Zone, Hubei Province
Doi:10.1007/BF01431320
(1996)Doi:10.1039/dt9960002857
(1996)Doi:10.1002/adsc.201500255
(2015)Doi:10.1016/0957-4166(96)00232-7
(1996)Doi:10.1021/ja304816e
(2012)Doi:10.1021/jo0300035
(2003)